Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | BBLG | Common Stock | 2.15K | Jan 17, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BBLG | Employee Stock Option | Award | $0 | +25K | $0.00 | 25K | Jan 17, 2024 | Common Stock | 25K | $3.61 | Direct | F1 | |
holding | BBLG | Employee Stock Option | 173 | Jan 17, 2024 | Common Stock | 173 | $9,540.00 | Direct | F2 | |||||
holding | BBLG | Employee Stock Option | 44 | Jan 17, 2024 | Common Stock | 44 | $12,300.00 | Direct | F2 | |||||
holding | BBLG | Employee Stock Option | 208 | Jan 17, 2024 | Common Stock | 208 | $892.80 | Direct | F2 | |||||
holding | BBLG | Employee Stock Option | 157 | Jan 17, 2024 | Common Stock | 157 | $57.60 | Direct | F2 |
Id | Content |
---|---|
F1 | This option was granted under the Bone Biologics Corporation 2015 Equity Incentive Plan, in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests and becomes exercisable immediately. |
F2 | This option is fully vested as of the date of this report. |